Qiu L - Search Results

1

Cancer Cell Membrane Camouflaged Mesoporous Silica Nanoparticles Combined with Immune Checkpoint Blockade for Regulating Tumor Microenvironment and Enhancing Antitumor Therapy.

Zhao P, Qiu L, Zhou S, Li L, Qian Z, Zhang H. Zhao P, et al. Among authors: qiu l. Int J Nanomedicine. 2021 Mar 12;16:2107-2121. doi: 10.2147/IJN.S295565. eCollection 2021. Int J Nanomedicine. 2021. PMID: 33737808 Free PMC article.

2

[DNCE regimen for treatment of refractory or relapsed aggressive and highly aggressive non-Hodgkin lymphoma].

Liu XM, Wang HQ, Zhang HL, Qiu LH, Li W, Li LF, Cui XZ, Liu PF, Hao XS. Liu XM, et al. Zhonghua Zhong Liu Za Zhi. 2008 Oct;30(10):779-82. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19173813 Clinical Trial. Chinese.

3

[Clinical characteristics and treatment analysis of primary breast lymphoma: 49 cases report].

Qiu LH, Wang HQ, Qian ZZ, Li W, Hou Y, Meng XR, Cui XZ, Hao XS. Qiu LH, et al. Zhonghua Wai Ke Za Zhi. 2010 May 15;48(10):743-6. Zhonghua Wai Ke Za Zhi. 2010. PMID: 20646489 Chinese.

4

Capecitabine combined with weekly docetaxel in Chinese patients > 65 years with anthracycline-resistant metastatic breast cancer.

Wang HQ, Qian ZZ, Liu XM, Zhang HL, Li LF, Qiu LH, Hou Y, Zhou SY, Hao XS, Xie CH. Wang HQ, et al. Chin Med J (Engl). 2010 Nov;123(22):3212-6. Chin Med J (Engl). 2010. PMID: 21163117 Clinical Trial.

5

[Nimotuzumab in combination with chemotherapy in patients with advanced non-small cell lung cancer].

Li LF, Wang HQ, Liu XM, Zhang HL, Qiu LH, Qian ZZ, Li W. Li LF, et al. Zhonghua Zhong Liu Za Zhi. 2011 Aug;33(8):626-8. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 22325226 Chinese.

6

[Expression of Cdc7 and mcm2 as a marker for proliferation and prognosis in diffuse large B cell lymphoma].

Hou Y, Wang HQ, Fu K, Zhang HL, Qian ZZ, Qiu LH, Li W, Zhou SY, Li LF, Hao XS. Hou Y, et al. Zhonghua Zhong Liu Za Zhi. 2011 Dec;33(12):911-5. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 22340100 Chinese.

7

[Efficacy and survival status of retuximab-NCE regimen treatment in patients with relapsed or refractory B cell non-Hodgkin's lymphoma].

Hou Y, Wang HQ, Fu K, Liu XM, Zhang HL, Qian ZZ, Qiu LH, Li W, Zhou SY, Li LF, Hao XS. Hou Y, et al. Zhonghua Zhong Liu Za Zhi. 2012 Apr;34(4):306-10. doi: 10.3760/cma.j.issn.0253-3766.2012.04.015. Zhonghua Zhong Liu Za Zhi. 2012. PMID: 22781046 Chinese.

8

Risk of second malignant neoplasms after cyclophosphamide-based chemotherapy with or without radiotherapy for non-Hodgkin lymphoma.

Xu Y, Wang H, Zhou S, Yu M, Wang X, Fu K, Qian Z, Zhang H, Qiu L, Liu X, Wang P. Xu Y, et al. Among authors: qiu l. Leuk Lymphoma. 2013 Jul;54(7):1396-404. doi: 10.3109/10428194.2012.743657. Epub 2012 Nov 26. Leuk Lymphoma. 2013. PMID: 23101661

9

Evaluation of toxicity and single-dose pharmacokinetics of intravenous ursolic acid liposomes in healthy adult volunteers and patients with advanced solid tumors.

Wang XH, Zhou SY, Qian ZZ, Zhang HL, Qiu LH, Song Z, Zhao J, Wang P, Hao XS, Wang HQ. Wang XH, et al. Expert Opin Drug Metab Toxicol. 2013 Feb;9(2):117-25. doi: 10.1517/17425255.2013.738667. Epub 2012 Nov 8. Expert Opin Drug Metab Toxicol. 2013. PMID: 23134084 Clinical Trial.

10

[Expression and prognostic value of regulatory T cells and M2 macrophages in diffuse large B-cell lymphoma tissues].

Xu YL, Wang HQ, Qian ZZ, Song Z, Zhou SY, Zhang HL, Qiu LH, Wang XH, Wang P. Xu YL, et al. Zhonghua Zhong Liu Za Zhi. 2013 Jun;35(6):450-5. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 24119906 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,821 results

Search Page

Filters